Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.460
-0.150 (-5.75%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Xenetic Biosciences Statistics

Total Valuation

XBIO has a market cap or net worth of $3.79 million. The enterprise value is -$2.37 million.

Market Cap 3.79M
Enterprise Value -2.37M

Important Dates

The last earnings date was Tuesday, March 18, 2025, after market close.

Earnings Date Mar 18, 2025
Ex-Dividend Date n/a

Share Statistics

XBIO has 1.54 million shares outstanding. The number of shares has increased by 0.86% in one year.

Current Share Class 1.54M
Shares Outstanding 1.54M
Shares Change (YoY) +0.86%
Shares Change (QoQ) +0.03%
Owned by Insiders (%) 7.28%
Owned by Institutions (%) 6.44%
Float 1.18M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.61
Forward PS 2.73
PB Ratio 0.67
P/TBV Ratio 0.63
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.37

Current Ratio 7.37
Quick Ratio 6.89
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -50.12% and return on invested capital (ROIC) is -33.26%.

Return on Equity (ROE) -50.12%
Return on Assets (ROA) -30.02%
Return on Invested Capital (ROIC) -33.26%
Return on Capital Employed (ROCE) -69.99%
Revenue Per Employee $1.25M
Profits Per Employee -$1.98M
Employee Count 2
Asset Turnover 0.29
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -30.11% in the last 52 weeks. The beta is 2.18, so XBIO's price volatility has been higher than the market average.

Beta (5Y) 2.18
52-Week Price Change -30.11%
50-Day Moving Average 3.83
200-Day Moving Average 3.96
Relative Strength Index (RSI) 20.76
Average Volume (20 Days) 6,638

Short Selling Information

The latest short interest is 4,534, so 0.29% of the outstanding shares have been sold short.

Short Interest 4,534
Short Previous Month 8,353
Short % of Shares Out 0.29%
Short % of Float 0.39%
Short Ratio (days to cover) 0.96

Income Statement

In the last 12 months, XBIO had revenue of $2.50 million and -$3.96 million in losses. Loss per share was -$2.57.

Revenue 2.50M
Gross Profit 2.50M
Operating Income -4.20M
Pretax Income -4.47M
Net Income -3.96M
EBITDA n/a
EBIT -4.20M
Loss Per Share -$2.57
Full Income Statement

Balance Sheet

The company has $6.17 million in cash and n/a in debt, giving a net cash position of $6.17 million or $4.00 per share.

Cash & Cash Equivalents 6.17M
Total Debt n/a
Net Cash 6.17M
Net Cash Per Share $4.00
Equity (Book Value) 6.01M
Book Value Per Share 3.89
Working Capital 5.69M
Full Balance Sheet

Cash Flow

Operating Cash Flow -2.82M
Capital Expenditures n/a
Free Cash Flow -2.82M
FCF Per Share -$1.83
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -168.16% and -158.39%.

Gross Margin 100.00%
Operating Margin -168.16%
Pretax Margin -158.39%
Profit Margin -158.39%
EBITDA Margin n/a
EBIT Margin -168.16%
FCF Margin n/a

Dividends & Yields

XBIO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.86%
Shareholder Yield -0.86%
Earnings Yield -104.39%
FCF Yield -74.27%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus Hold
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on May 15, 2023. It was a reverse split with a ratio of 0.1:1.

Last Split Date May 15, 2023
Split Type Reverse
Split Ratio 0.1:1

Scores

XBIO has an Altman Z-Score of -36.57 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -36.57
Piotroski F-Score 2